OTC · Drug Manufacturers - Specialty & Generic

Hempfusion Wellness Inc. (CBDHF) Stock

$0.00 OTC: CBDHF Healthcare

Hempfusion Wellness Inc., a health and wellness enterprise based in Vancouver, Canada, specializes in the development, promotion, and distribution of natural hemp-derived supplements and probiotic offerings throughout the United States. The company's diverse product lineup features tinctures, capsules, and topical creams under its HempFusion brand, while also providing digestive enzymes, probiotics, and skincare solutions through its Probulin brand.

Valuation

MetricValue
Price$0.00
Market Cap$1635
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE0.00%
ROA0.00%
ROCE-267.54%
Gross Margin100.00%
Operating Margin100.00%
Net Margin0.00%
Debt/Equity-0.06
Current Ratio0.78

Annual Financials (USD)

Metric20172018201920202021
Revenue$1.0M$1.0M$3.0M$4.0M$9.0M
Operating Profit$-1.0M$-1.0M$-12.0M$-19.0M$9.0M
Net Profit$-1.0M$-2.0M$-12.0M$-38.0M$0
EPS$-0.01$-0.01$-0.12$-0.38$0.00
Op Margin-130.5%-117.4%-407.3%-504.5%100.0%

Balance Sheet (USD)

Metric20172018201920202021
Total Assets$2.0M$4.0M$39.0M$14.0M—
Total Liabilities$2.0M$0$8.0M$18.0M—
Cash$0$1.0M$26.0M$9.0M—
Borrowings$2.0M$0$0$0$0

Cash Flow (USD)

Metric20172018201920202021
Operating Cash Flow$-2.0M$-2.0M$-12.0M$-15.0M—
Investing Cash Flow$0$0$-5.0M$-2.0M—
Financing Cash Flow$0$0$0$0—
Net Cash Flow$0$1.0M$25.0M$-17.0M—
Free Cash Flow$-2.0M$-2.0M$-12.0M$-15.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.00
FCF Yield-924454.56%
Quick Ratio0.63
Interest Coverage0.00
Return 1Y0.00%
Return 3Y-90.00%
Return 5Y—

Ownership

Insiders Held11.02%
Institutions Held6.02%
Institutions Float Held6.77%
Institutional HolderSharesReport Date
AdvisorShares Investments, LLC2,388,1032026-03-31
FCA Corp /TX22,2222026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Hempfusion Wellness Inc.

Hempfusion Wellness Inc., a health and wellness enterprise based in Vancouver, Canada, specializes in the development, promotion, and distribution of natural hemp-derived supplements and probiotic offerings throughout the United States. The company's diverse product lineup features tinctures, capsules, and topical creams under its HempFusion brand, while also providing digestive enzymes, probiotics, and skincare solutions through its Probulin brand. Additionally, it offers products under the HF Labs and Biome Research labels. These goods are accessible to consumers via its dedicated e-commerce platforms, through medical practitioners, and across a wide network of retailers, including grocery stores, pharmacies, large-scale general merchandise outlets, and convenience stores.

Hempfusion Wellness Inc. (CBDHF) stock trades at $0.00 with a market capitalization of $1635. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Hempfusion Wellness Inc. generates a return on equity (ROE) of 0.00%, return on capital employed of -267.54%, an operating margin of 100.00%, a net profit margin of 0.00%.

Official website: www.thebestturkishkebab.com/menu

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides